feed,title,long_url,short_url
Benzinga,"Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics",https://benzinga.com/analyst-ratings/analyst-color/23/02/30672964/being-cautious-on-regulatorycommercial-path-this-analyst-initiates-coverage-on-verv,https://da.gd/qbRY8
Benzinga,"Spotify's Profitability Likely To Breakeven Driven By Subscription Pricing Power And Expense Discipline, Analysts Say",https://benzinga.com/news/23/02/30673013/spotifys-profitability-likely-to-breakeven-driven-by-subscription-pricing-power-and-expense-discipli,https://da.gd/b0vHhP
